Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GISSI-HF: n-3 PUFA and Rosuvastatin in Heart Failure
NCT00336336Phase 3Completed
- Sponsor
- GISSI
- Start
- Aug 2002
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of omega-3 fatty acid, rosuvastatin in heart failure (HF), sponsored by GISSI. Started Aug 2002; status: completed.
02
Drugs
omega-3 fatty acidrosuvastatin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00336336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336336.